Keynote Speakers

• Doctor William Jarvis
• Doctor Robert Weinstein
• Professor Andreas Widmer
• Professor Anthony McMichael
• Professor Didier Pittet
• Doctor William Rutala

Doctor William Jarvis , MD, FAAP, FIDSA, FSHEA is President and co-founder of Jason and Jarvis Associates, a private consulting firm in healthcare epidemiology.

Previously, Dr. Jarvis spent twenty-three years at the U.S. Centers for Disease Control and Prevention in Atlanta, Georgia where he held a number of supervisory positions in epidemiology, research and infectious diseases. In his most recent role at the CDC, Dr. Jarvis was the Director, Office of Extramural Research, Office of the Director, National Center for Infectious Diseases where he was responsible for starting and building the first office of extramural research in the CDC's National Center for Infectious Diseases and funded over $10 million in grants.

Prior to his role as the Director of the Office of Extramural Research, Dr. Jarvis spent 22 years working for the CDC’s Hospital Infections Program (HIP; now known as the Division of Healthcare Quality Promotion). He was responsible for the supervision of the investigation of all outbreaks and epidemiologic studies in healthcare settings and for developing all CDC guidelines for prevention of infection in healthcare settings. He was also responsible for training Epidemic Intelligence Service (EIS) officers in epidemiologic methods and outbreak investigation. In addition, he served as Acting Director, HIP, CDC.
Full Bio

Professor Tony McMichael (MBBS, PhD), epidemiologist, currently holds an NHMRC Australia Fellowship at the Australian National University, Canberra. He was previously Professor of Epidemiology at the London School of Hygiene and Tropical Medicine. He is an advisor to the World Health Organization on climate change and health, long-time contributor to health risk assessment for the UN’s Intergovernmental Panel on Climate Change (IPCC), Chair of a reference panel for the WHO-based Tropical (Infectious) Diseases Research Program, participant in the Australian Biosecurity Cooperative Research Centre (2002-2009), and Honorary Professor of Climate Change and Health at the University of Copenhagen. His most recent books are Human Frontiers and Disease: Past Patterns, Uncertain Futures (Cambridge University Press, 2001) and (as senior editor and author) Climate Change and Human Health: Risks and Responses (Geneva: WHO, 2003).
Full Bio

Professor Didier Pittet, MD, MS is the Hospital Epidemiologist and Director of the Infection Control Program at the University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland; Professor of Medicine and Hospital Epidemiology at the University of Geneva; and Attending Physician in Adult and Paediatric Infectious Diseases, University of Geneva Hospitals. He holds Honorary Professorships at Imperial College London, UK, the Faculty of Health and Social Sciences, Hong Kong Polytechnic University School of Health Science, and the First Medical School of the Fu, Shanghai, China.
Full Bio

Doctor Robert Weinsteinis the Chairman of the Department of Medicine for the Cook County Health and Hospitals System and at the John Stroger (formerly Cook County) Hospital; the Chief Operating Officer of the outpatient Ruth M. Rothstein CORE Center for the Prevention, Care, and Research of Infectious Diseases; and the C. Anderson Hedberg MD Professor of Internal Medicine at Rush University Medical College-all in Chicago Illinois, USA.
Full Bio

Doctor William Jarvis

William Robert Jarvis, MD, FAAP, FIDSA, FSHEA is President and co-founder of Jason and Jarvis Associates, a private consulting firm in healthcare epidemiology.

Previously, Dr. Jarvis spent twenty-three years at the U.S. Centers for Disease Control and Prevention in Atlanta, Georgia where he held a number of supervisory positions in epidemiology, research and infectious diseases. In his most recent role at the CDC, Dr. Jarvis was the Director, Office of Extramural Research, Office of the Director, National Center for Infectious Diseases where he was responsible for starting and building the first office of extramural research in the CDC's National Center for Infectious Diseases and funded over $10 million in grants.

Prior to his role as the Director of the Office of Extramural Research, Dr. Jarvis spent 22 years working for the CDC’s Hospital Infections Program (HIP; now known as the Division of Healthcare Quality Promotion). He was responsible for the supervision of the investigation of all outbreaks and epidemiologic studies in healthcare settings and for developing all CDC guidelines for prevention of infection in healthcare settings. He was also responsible for training Epidemic Intelligence Service (EIS) officers in epidemiologic methods and outbreak investigation. In addition, he served as Acting Director, HIP, CDC.

Since 1985, Dr. Jarvis has served as a Clinical Associate Professor at Emory University in the Division of Pediatric Infectious Diseases, Epidemiology and Immunology of the Department of Pediatrics. Additionally, he has served since 1990 as Clinical Assistant Professor at Emory University in the Department of Epidemiology.

Dr. Jarvis has held many society positions including member or fellow of the Infectious Diseases Society of America, American Academy of Pediatrics, American Society for Microbiology (ASM), Society for Healthcare Epidemiology of America (SHEA), Association for Professions in Infection Control and Epidemiology (APIC), Society for Pediatric Research, American Academy of Pediatrics and the Pediatric Infectious Diseases Society. He has been President, SHEA; Chair, Division L (Nosocomial Infections), ASM; and President of the APIC Research Foundation. In addition from 2004-2007, he was editor of Infection Control and Hospital Epidemiology, the SHEA journal.

Dr. Jarvis has published over 450 peer-reviewed publications, 60 book chapters, 54 surveillance reports (MMWRs) and is the Editor of two books, including the recently published Hospital Infections, 5^th Edition. He has received numerous awards including the Spark's Memorial Award for Academic Excellence, CDC Lifetime Scientific Achievement Award, SHEA Lectureship and APIC State of the Science Scientific Excellence awards. Recently, he has been the PI of the first national inpatient MRSA survey in the United States and has led a multinational team examining the role of mechanical valves in increased BSI rates.

A licensed practitioner in Georgia, Texas and California, Dr. Jarvis received his M.D. from the University of Texas Health Sciences Center, Houston. He also has a B.S. in Psychology from the University of California, Davis.

Doctor Robert Weinstein

Dr. Weinstein is the Chairman of the Department of Medicine for the Cook County Health and Hospitals System and at the John Stroger (formerly Cook County) Hospital; the Chief Operating Officer of the outpatient Ruth M. Rothstein CORE Center for the Prevention, Care, and Research of Infectious Diseases; and the C. Anderson Hedberg MD Professor of Internal Medicine at Rush University Medical College-all in Chicago Illinois, USA.

Dr. Weinstein's clinical and research interests focus on healthcare-acquired infections (particularly the epidemiology, costs, and prevention of antimicrobial resistance and of infections in intensive care units), rapid HIV testing, and healthcare costs and outcomes for patients with HIV/AIDS.

Dr. Weinstein is a past-president of the Society for Healthcare Epidemiology of America (SHEA) and immediate past-chair of the CDC's Healthcare Infection Control Practices Advisory Committee (HICPAC). He was a 1999 recipient of the National Association of Public Hospitals and Health Systems "Clinical Research Award", the 2005 recipient of the SHEA Lectureship Award, the 2008 recipient of the SHEA Mentor Award, and honored with a Lifetime Achievement Award from the CDC in 2010. Dr. Weinstein has published >275 scientific articles, 48 book chapters, 2 books, and 22 CDs and internet educational materials.

Professor Dr Andreas F. Widmer MD,MS

Prof. A.F. Widmer earned his MD degree in Switzerland, where he completed his fellowship in internal medicine in several hospitals. He founded the specialty infectious diseases as the secretary of the Swiss Society for Infectious Diseases back in 1998. He was trained in hospital epidemiology by R. Wenzel, in Iowa, IA, USA, where he completed his master degree in epidemiology at the University of Iowa. He is a core member in the "patient safety" program of the WHO, past President of the Swiss Society for Hospital Epidemiology, editorial advisory board member of the journal "Clinical Infectious Diseases". In addition, he is in the guidelines committee of the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Disease Society of America (IDSA), and treasurer of the European Study Group on Nosocomial Infections (ESGNI). His research interests are control of multiresistant pathogens such as MRSA, surgical site infections, in particular implant-associated infections, and C. difficile infections. His current position is deputy head of the division of infectious diseases and hospital epidemiology, and head of hospital epidemiology at the University Hospital Basel, Switzerland.

Professor Didier Pittet

Didier Pittet, MD, MS is the Hospital Epidemiologist and Director of the Infection Control Program at the University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland; Professor of Medicine and Hospital Epidemiology at the University of Geneva; and Attending Physician in Adult and Paediatric Infectious Diseases, University of Geneva Hospitals. He holds Honorary Professorships at Imperial College London, UK, the Faculty of Health and Social Sciences, Hong Kong Polytechnic University School of Health Science, and the First Medical School of the Fu, Shanghai, China.

Professor Pittet is Lead of the World Health Organization First Global Patient Safety Challenge “Clean Care is Safe Care”. He is the recipient of several national and international honours including a CBE (Commander of the British Empire) awarded by Her Majesty Queen Elisabeth II for services to the prevention of healthcare-associated infection in the UK (2007), the Society for Healthcare Epidemiology of America Lectureship for his contribution to infection control and healthcare epidemiology (2008), and the European Society of Clinical Microbiology and Infectious Diseases’ Award for Excellence (2009).

Professor Pittet is co-author of more than 300 publications and several chapters in textbooks; his current research interests include the epidemiology and prevention of healthcare-associated infections, methods for improving compliance with barrier precautions and hand hygiene practices, as well as methods for improving the quality of patient care and patient safety. He is also involved in research on the epidemiology of infectious diseases.

Dr William Rutala

William A. Rutala, Ph.D., M.P.H
Professor, Division of Infectious Diseases, Department of Medicine, Director, Statewide Program for Infection Control and Epidemiology University of North Carolina School of Medicine (Chapel Hill) Director, Hospital Epidemiology, Occupational Health, and Safety Program at UNC Health Care System

Dr. Bill Rutala is a Professor for the Division of Infectious Diseases at the University of North Carolina's School of Medicine, and serves as the Director of Hospital Epidemiology, Occupational Health and Safety Program at the University of North Carolina Health Care System. He is also Director and co-founder of the Statewide Program for Infection Control and Epidemiology at the UNC School of Medicine and a retired Colonel with the U.S. Army Reserve. Dr. Rutala is certified in infection control. He is an advisor to the Centers for Disease Control and Prevention (a former member of the Healthcare Infection Control Practices Advisory Committee [HICPAC], 1999-2003), the Food and Drug Administration (a former member of the General Hospital and Personal Use Devices Panel), the U.S. Environmental Protection Agency (a member of the Scientific Advisory Panel on Antimicrobial Research Strategies for Disinfectants) and the Federal Trade Commission. Dr. Rutala is a member of various committees on the local, state, national and international level as well as several professional societies including the American Society for Microbiology, Association for Professionals in Infection Control and Epidemiology and the Society of Healthcare Epidemiology of America. He serves on the editorial board of the Infection Control and Hospital Epidemiology. He has over 450 publications in the fields of infectious diseases, infection control, disinfection, sterilization and medical waste to include several guidelines (e.g., CDC Guideline for Disinfection and Sterilization in Healthcare Facilities). Dr. Rutala has also been an invited lecturer at over 300 state, national and international conferences (in over 40 states and 25 countries) and has testified twice before the U.S. Congress. Dr. Rutala earned his Bachelor of Science degree in science from Rutgers University, his master's degree in microbiology from the University of Tennessee and both his master's in public health and doctorate in microbiology from the University of North Carolina School of Public Health.

Professor Frank Bowden

Frank Bowden is Professor of Medicine at the Australian National University Medical School. He is an Infectious Diseases and Sexual Health Physician in Canberra. He trained at St Vincent's Hospital and Fairfield Infectious Diseases Hospital in Melbourne and worked in the Northern Territory in the 1990s. His research currently focuses on the development of public health approaches to the control of sexually transmitted infections and head lice. He is the author of 'Gone Viral – the germs that share our lives', published by New South Books.

Professor Martyn Jeggo

Professor Martyn Jeggo is the Director of CSIRO's Australian Animal Health Laboratory (AAHL). AAHL is a global leader in research into and diagnosis of major diseases affecting livestock throughout the world. The Laboratory is a frontline defence, helping to protect Australia from the threat of exotic and emerging animal diseases. In 2004, AAHL was designated as an international collaborating centre for new and emerging diseases by the World Organization for Animal Health (OIE). This designation places AAHL at the forefront of international efforts to manage the growing number of disease agents that pose a risk to animal and human health.

Dr Luke Chen

Dr Luke F. Chen, MBBS (Hons), MPH the Department of Medicine, Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina. Dr Chen is an emerging leader in the field of infection prevention and control In the in the USA .

Dr. Chen graduated with honors from the School of Medicine at University of Melbourne in Australia. He recently graduated from the Bloomberg School of Public Health at Johns Hopkins University and was admitted in the Delta Omega Public Health Honors Society. Currently, he is an Assistant Professor of Medicine in the Division of Infectious Diseases and International Health at Duke University, Durham, North Carolina.

He is the co-medical director of Duke's Program for Infection Prevention and Healthcare Epidemiology. Additionally, he is a faculty member of the Duke Infection Control Outreach Network (DICON) which collaborates with more than 40 community hospitals and ambulatory care centers in southeastern United States. He is a co-investigator in the CDC's Prevention Epicenter Program at Duke University.

Invited Speakers

• Dr Apisarnthanarak, Thammasat University Hospital Pratumthani, Thailand
• Wendy Bacalja, The Royal Dental Hospital of Melbourne, Victoria, Australia
• Dr Noleen Bennett, VICNISS Coordinating Centre, Victoria, Australia
• Sandy Berenger, Hunter New England Local Health Network, NSW, Australia
• Claire Boardman, Torres Strait and Northern Peninsula Health Services District, Queensland, Australia
• Sue Borrell, Alfred Health, Victoria, Australia
• Judith Brett, VICNISS Coordinating Centre, Victoria, Australia
• Dr Kirsty Buising, St Vincent's Hospital Melbourne, Victoria, Australia
• Dr Ann Bull, VICNISS Coordinating Centre, Victoria, Australia
• Maureen Canning, Peninsula Health, Victoria, Australia
• Prof Ben Canny, Monash University, Victoria, Australia
• A/Prof Allen Cheng, Monash University & Alfred Health, Victoria, Australia
• Patricia Ching, Queen Mary Hospital, Hong Kong Health Authority, Hong Kong
• Deidre Edmonds, Austin Health, Victoria, Australia
• Prof Don Esmore AO, Alfred Health, Victoria, Australia
• Dr John Ferguson, Hunter New England Health, NSW, Australia
• Karen Flett, Alfred Health, Victoria, Australia
• Elizabeth Gillespie, Southern Health, Victoria, Australia
• Prof Nicholas Graves, Queensland University of Technology, Queensland, Australia
• Prof Lindsay Grayson, Austin Health, Victoria, Australia
• Gabrielle Hanlon, Australian and New Zealand Intensive Care Society, Victoria, Australia
• Anne Hardy, Knox Private Hospital, Victoria, Australia
• Glenys Harrington, Infection Control Consultancy (ICC), Victoria, Australia
• Louise Hobbs, Melbourne Health, Victoria, Australia
• Leanne Houston, Eastern Health Victoria, Australia
• Prof Po-Ren Hsueh, National Taiwan University Hospital, Taiwan
• A/Prof Jon Iredell, University of Sydney & Westmead Hospital, NSW, Australia-
• Prof Anne Kelso, WHO Collaborating Centre for Reference and Research on Influenza, Australia
• Elizabeth Kennedy, Epworth Healthcare, Victoria, Australia
• Claire Kirkpatrick, World Health Organisation, Switzerland
• Gillian Land, Alfred Health, Victoria, Australia
• Dr Sang-Oh Lee, University of Ulsan, Republic of Korea
• Penny Leszkiewicz, Alfred Health, Victoria, Australia
• Dr Moi Lin Ling, Singapore General Hospital & President, Asia Pacific Society of Infection Control, Singapore
• Dr Mark Lubliner, Cabrini Health, Victoria, Australia
• Prof Rainer MacIntyre, The Children's Hospital at Westmead & The University of Sydney, NSW, Australia
• A/Prof Matthias Maiwald, KK Women's and Children's Hospital, Singapore
• Dr Caroline Marshall, Royal Melbourne Hospital & University of Melbourne, Victoria, Australia
• Rhea Martin, Austin Health, Victoria, Australia
• Dr Deborough Macbeth, Gold Coast Health Service District, Queensland, Australia
• Dr Andrew Mahony, Department of Health Victoria, Australia
• Prof Mary-Louise McLaws, The University of New South Wales, NSW, Australia
• Brett Mitchell, Tasmanian Infection Control Association, Tasmania, Australia
• Mark Mitchell, Billard Leece Partnership, Victoria, Australia
• Marion Moloney, Department of Health, Victoria, Australia
• Rodney Moran, Department of Health Victoria, Australia
• A/Prof Cathryn Murphy, APIC Immediate Past President & Gold Coast District Health Service, Queensland, Australia
• Kate O'Donaghue, VICPA Executive, Australia
• A/Prof Susan O'Neill, Cabrini Health, Victoria, Australia
• Dr Mary O'Reilly, Eastern Health, Victoria, Australia
• Prof David Paterson, University of Queensland Centre for Clinical Research (UQCCR), Queensland, Australia
• Dr Anton Peleg, Alfred Health & Monash University, Victoria, Australia and Beth Israel Deaconess Medical Centre, USA
• Prof Michael Richards, VICNISS Coordinating Centre, Victoria, Australia
• Jane Roberts, Peninsula Health, Victoria, Australia
• Nicolette Rossouw, Epworth Eastern, Epworth HealthCare, Australia
• Phil Russo, Hand Hygiene Australia, Victoria, Australia
• Sue Scott, Royal Children's Hospital, Victoria, Australia
• Prof Wing-Hong Seto, Queen Mary Hospital & WHO Collaborating Centre for Infection Control, Hospital Authority, Hong Kong
• Dr Monica Slavin, Peter MacCallum Cancer Institute, Victoria, Australia
• Dr Sok Srun, Ministry of Health, Cambodia
• Dr Rhonda Stuart, Southern Health, Victoria, Australia
• Prof James Tatoulis, Royal Melbourne Hospital & University of Melbourne, Victoria, Australia
• Maggy Tomkins, SafeHandS, Albion Street Centre, NSW, Australia
• Kerrie Watson, Alfred Health, Victoria, Australia
• Prof Michael Whitby, University of Queensland, Queensland, Australia
• Beth Wilson, Health Services Commissioner, Victoria, Australia
• Pauline Woodburn, Bendigo Health, Victoria, Australia
• Dr Leon Worth, VICNISS Coordinating Centre, Victoria, Australia

Pre Congress Workshops

The APSIC 2011 Organising Committee is pleased to offer Congress delegates the choice of six half-day pre congress workshops. The workshops and their presenters have been carefully selected by the Committee to complement the Congress Scientific Program and provide participants with a unique opportunity to undertake further professional development in conjunction with the Congress.

The workshops will be held on Tuesday, 8 November 2011.

• Workshop 1 - Simulation Training in Outbreak Management and Isolation Strategies
• Workshop 2 - Epidemiology and Surveillance
• Workshop 3 - Infection Control in Practice - Spend a Morning with a Melbourne Infection Control
• Workshop 4 - Essential Skills for Quality Improvement Research in Infection Control - An Introduction
• Workshop 5 - Reading, Writing and Understanding Journal Articles
• Workshop 6 - Preparing for International Accreditation
• Sponsor Workshop and Symposia

Please note, participation in the Pre Congress Workshops is not included in the Congress Registration fee. The Workshop fees for delegates are listed detailed in the workshop information and include either Morning or Afternoon Tea.

Workshop 1

Title: Simulation Training in Outbreak Management and Isolation Strategies
Date: Tuesday, 8 November 2011
Time: 09:00-12:00
Cost: AUD 75.00
Venue: Australian Centre for Health Innovation (return coach transfers from the MCEC will be provided)
Presenter: Glenys Harrington, Infection Control Consultancy (ICC)
Learning Objectives:
Outbreaks can consume significant time, effort and infection control resources. Outbreaks represent the occurrence of healthcare associated infections at an increased incidence above background rates or baseline in a defined patient population.

This workshop will include simulated scenarios and group work to investigate outbreaks and implement appropriate isolation strategies.

On completion of the workshop participants will have an understanding of and be able to demonstrate the following:

• The scope of hospital acquired infection outbreaks
• A step by step approach to the investigation of an outbreak in a healthcare setting
• Develop a line listing and epidemic curve
• How to implementation of control measures including appropriate isolation precautions

Workshop 2

Title: Epidemiology and Surveillance
Date: Tuesday, 8 November 2011
Time: 09:00-12:00
Cost: AUD 75.00
Venue: Melbourne Convention and Exhibition Centre
Presenter: Dr Noleen Bennett, Dr Ann Bull and Judith Brett, VICNISS

Learning objectives:
Without epidemiology and surveillance there is no systematic, continuous way for monitoring healthcare associated infection. By collecting and analysing epidemiological and surveillance data infection control infection control staff are able to identify outbreaks or problem areas and devise and implement interventions to reduce hospital associated infections and improve the quality of health care.

On completion of the workshops participants will have an understanding of and be able to demonstrate the following:

• How an active surveillance program can reduce hospital associated infections
• The importance of case definitions
• Numerator and denominator data as a measure of hospital associated infection frequency
• The key components of a surveillance system
• Plan, demonstrate and implement a surveillance program with limited resources

Workshop 3

Title: Infection Control in Practice - Spend a Morning with a Melbourne Infection Control Team
Date: Tuesday, 8 November 2011
Time: 09:00-12:00
Cost: AUD 75.00
Venue: Selected Hospitals (return coach transfers from the MCEC will be provided)
Presenter: Gillian Land, Infection Control and Hospital Epidemiology Unit, Alfred Health
Learning objectives:
Visit a Melbourne Infection Control multidisciplinary team for a morning. See how these teams coordinate their infection control programs including surveillance, implementing evidence based interventions, measuring outcomes and engaging with clinical staff on a day to day basis. This is an interactive workshop and participants will "buddy" with an infection control team member for the morning while they conduct their day to day core infection control activities.

On completion of the workshops participants will have an understanding of and be able to demonstrate the following:

• Establishing a multidisciplinary infection control team
• How multidisciplinary teams work:
• Annual planning
• Portfolios
• Surveillance programs
• Interventions strategies
• Infection control meetings (team & committee)

Workshop 4

Title: Essential Skills for Quality Improvement Research in Infection Control -
An Introduction
Date: Tuesday, 8 November 2011
Time: 13:00-16:00
Cost: AUD 75.00
Venue: Melbourne Convention and Exhibition Centre
Presenter: Kerrie Watson, Infectious Diseases Unit, Alfred Health
Learning objectives:
Measurement is critical to the quality improvement process. The quality improvement journey includes having an aim, measurement, operational definition, data collection plan, data collection and analysis.

Avoiding the pitfalls that can be associated with aggregate data, summary statistics and tabular formats will be discussed along with understanding variation for quality improvement.

On completion of the workshops participants will have an understanding of and be able to demonstrate the following:

• Identifying interventions that have been shown to decrease hospital associated infection
• Developing and testing tools to measure intervention strategies to decrease hospital associated infection
• Establishing a "Quality Improvement Team"
• Analysing quality improvement data using statistical process control charts

Workshop 5

Title: Reading, Writing and Understanding Journal Articles
Date: Tuesday, 8 November 2011
Time: 13:00-16:00
Cost: AUD 75.00
Venue: Melbourne Convention and Exhibition Centre
Presenter: Elizabeth Gillespie, Infection Control, Southern Health
Learning Obejetives:
The ever expanding role of infection control makes it difficult to keep up to date with the current literature and share our research and quality improvement activities with peers through publication.

This workshop will help participants develop and build strategies into their infection control programs to help keep up to date with the literature and practice getting their ideas on paper.

On completion of the workshop participants will have an understanding of and be able to demonstrate the following:

• Different types of publications
• Strategies to keep up to date with the current literature
• How to use findings in publications in your day to day practice
• How to get your ideas on paper:

* Introduction - Why did you do something?
* Method - What did you do?
* Results - What did you find?
* Discussion - What does it mean?

Workshop 6

Title: Preparing for International Accreditation
Date: Tuesday, 8 November 2011
Time: 13:00-16:00
Cost: AUD 75.00
Venue: Melbourne Convention and Exhibition Centre
Presenters: Dr Moi Lin Ling, Director Infection Control Department, Singapore General Hospital & President, Asia Pacific Society of Infection Control
Patricia Ching, Infection Control Specialist, Infection Control & Quality Improvement, Queen Mary Hospital, Hong Kong Health Authority
Learning Objectives:
Accreditation is a status achieved by healthcare facilities that have been assessed and been shown to have met particular standards following an independent review process to assesses their performance. The objective of accreditation is to improving the quality and safety of healthcare.

On completion of the workshops participants will have an understanding of and be able to demonstrate the following:

• Continuous quality improvement in an infection control program
• Mandatory criteria for infection control system in international accreditation
• Performance indicators for international accreditation
• Preparation prior to survey
• Development of an evidence folder
• Internal and external benchmarking

Sponsor Workshop and Symposia

Tuesday, 8 November 2011
14:00-17:00 - BD Workshop
15:30-17:00 - Yoshida Pharmaceuticals Symposium

Wednesday, 9 November 2011
17:00-18:30 - Johnson & Johnson Symposium

Thursday, 10 November 2011
07:00-08:00 - Kimberly-Clark Breakfast Symposium
16:00-17:30 - Johnson & Johnson Symposium